Download PDF
Angewandte Nuklearmedizin 2023; 46(04): 323-330
DOI: 10.1055/a-2160-3035
Live(r), Laugh, Love – Bildgebung und Therapie primärer und sekundärer Lebertumore
Übersicht

Primäre und sekundäre Lebertumore

Primary and secondary liver tumors
Nabeel Mansour
1   Klinik und Poliklinik für Radiologie, LMU Klinikum, München
,
Max Seidensticker
1   Klinik und Poliklinik für Radiologie, LMU Klinikum, München
,
Maurice M. Heimer
1   Klinik und Poliklinik für Radiologie, LMU Klinikum, München
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Zusammenfassung

Die Leber kann von verschiedenen Malignomen betroffen sein. Bei gewissen Risikofaktoren steigt die Wahrscheinlichkeit der Entwicklung von lebereigenen Tumoren (primären Lebertumoren) an. Die häufigsten Tumormanifestationen sind allerdings sekundär durch Metastasen bedingt. Zwischen den verschiedenen zur Verfügung stehenden radiologischen Modalitäten bestehen in der Detektion und Charakterisierung von Leberläsionen relevante Unterschiede. Dabei werden konventioneller und kontrastmittelverstärkter Ultraschall (CEUS), Computertomografie (CT) und die Magnetresonanztomografie (MRT) routinehaft eingesetzt. Diese Diagnostikmethoden weisen dabei im gegenseitigen Vergleich Vor- und Nachteile auf. Ziel dieser Übersichtsarbeit ist es, die Rolle der einzelnen Modalitäten, häufige Bildmerkmale und die Rolle der unterschiedlichen Kontrastmittel in der Diagnostik von primären und sekundären Lebertumoren zusammenzufassen.

Abstract

The liver can be affected by various malignancies. Certain risk factors increase the probability of developing primary liver tumors. However, the most common tumor manifestations are secondary in nature (metastases). There are significant differences in the detection and characterization of liver lesions among the various available radiological imaging modalities. Conventional and contrast-enhanced ultrasound (CEUS), computed tomography (CT) as well as magnetic resonance imaging (MRI) are routinely used. These diagnostic methods exhibit certain strengths and weaknesses when compared. The aim of this review is to summarize the role of each modality, the tumor-specific manifestations, and the role of different contrast agents in the diagnosis of primary and secondary liver tumors.

Schlüsselwörter

Primäre Lebertumore - Lebermetastasen - Kontrastmittelverstärkte Bildgebung

Keywords

Primary liver tumors - Liver metastases - contrast-enhanced imaging


Publication History

Article published online:
07 December 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Parkin DM, Bray F, Ferlay J. et al. Estimating the world cancer burden: Globocan 2000. International journal of cancer 2001; 94: 153-156
    CrossrefPubMedSearch in Google Scholar
  • 2 Mittal S, El-Serag HB. Epidemiology of HCC: consider the population. Journal of clinical gastroenterology 2013; 47 (Suppl. 00) S2-S6
    CrossrefPubMedSearch in Google Scholar
  • 3 Choo SP, Tan WL, Goh BK. et al. Comparison of hepatocellular carcinoma in E astern versus W estern populations. Cancer 2016; 122: 3430-3446
    CrossrefPubMedSearch in Google Scholar
  • 4 Liangpunsakul S, Haber P, McCaughan GW. Alcoholic liver disease in asia, europe, and north America. Gastroenterology 2016; 150: 1786-1797
    CrossrefPubMedSearch in Google Scholar
  • 5 Lee YJ, Lee JM, Lee JS. et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging – a systematic review and meta-analysis. Radiology 2015; 275: 97-109
    CrossrefPubMedSearch in Google Scholar
  • 6 Ricke J, Steffen IG, Bargellini I. et al. Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma. JHEP Rep 2020; 2: 100173
    CrossrefPubMedSearch in Google Scholar
  • 7 Semaan S, Vietti Violi N, Lewis S. et al. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid. European Radiology 2020; 30: 1020-1030
    CrossrefPubMedSearch in Google Scholar
  • 8 Renzulli M, Biselli M, Brocchi S. et al. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut 2018; 67: 1674-1682
    CrossrefPubMedSearch in Google Scholar
  • 9 Golfieri R, Garzillo G, Ascanio S. et al. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines. Digestive Diseases 2014; 32: 696-704
    CrossrefPubMedSearch in Google Scholar
  • 10 Horowitz JM, Kamel IR, Arif-Tiwari H. et al. ACR Appropriateness Criteria® Chronic Liver Disease. J Am Coll Radiol 2017; 14 (Suppl. 05) S391-S405
    CrossrefPubMedSearch in Google Scholar
  • 11 Chernyak V, Fowler KJ, Kamaya A. et al. Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 2018; 289: 816-830
    CrossrefPubMedSearch in Google Scholar
  • 12 Ralls P, Johnson M, Lee K. et al. Color Doppler sonography in hepatocellular carcinoma. American journal of physiologic imaging 1991; 6: 57-61
    PubMedSearch in Google Scholar
  • 13 Eisenbrey JR, Gabriel H, Savsani E. et al. Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies. Abdominal Radiology 2021; 46: 3579-3595
    CrossrefPubMedSearch in Google Scholar
  • 14 Mavros MN, Economopoulos KP, Alexiou VG. et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA surgery 2014; 149: 565-574
    CrossrefPubMedSearch in Google Scholar
  • 15 Zhang H, Yang T, Wu M. et al. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer letters 2016; 379: 198-205
    CrossrefPubMedSearch in Google Scholar
  • 16 Wang Y, Yang Q, Li S. et al. Imaging features of combined hepatocellular and cholangiocarcinoma compared with those of hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in a Chinese population. Clinical Radiology 2019; 74: 407.e1-407.e10
    CrossrefPubMedSearch in Google Scholar
  • 17 Jhaveri KS, Hosseini-Nik H. MRI of cholangiocarcinoma. Journal of Magnetic Resonance Imaging 2015; 42: 1165-1179
    CrossrefPubMedSearch in Google Scholar
  • 18 Horn SR, Stoltzfus KC, Lehrer EJ. et al. Epidemiology of liver metastases. Cancer Epidemiol 2020; 67: 101760
    CrossrefPubMedSearch in Google Scholar
  • 19 Ros PR, Rasmussen JF. Malignant liver tumors. Curr Probl Diagn Radiol 1989; 18: 95-124
    CrossrefPubMedSearch in Google Scholar
  • 20 Maclean D, Tsakok M, Gleeson F. et al. Comprehensive Imaging Characterization of Colorectal Liver Metastases. Front Oncol 2021; 11: 730854
    CrossrefPubMedSearch in Google Scholar
  • 21 Ozaki K, Higuchi S, Kimura H. et al. Liver Metastases: Correlation between Imaging Features and Pathomolecular Environments. Radiographics 2022; 42: 1994-2013
    CrossrefPubMedSearch in Google Scholar
  • 22 Choi J. Imaging of hepatic metastases. Cancer Control 2006; 13: 6-12
    CrossrefPubMedSearch in Google Scholar
  • 23 Kim HJ, Lee SS, Byun JH. et al. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. Radiology 2015; 274: 712-722
    CrossrefPubMedSearch in Google Scholar
  • 24 Blackledge MD, Leach MO, Collins DJ. et al. Computed diffusion-weighted MR imaging may improve tumor detection. Radiology 2011; 261: 573-581
    CrossrefPubMedSearch in Google Scholar
  • 25 Whatcott CJ, Diep CH, Jiang P. et al. Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer. Clin Cancer Res 2015; 21: 3561-3568
    CrossrefPubMedSearch in Google Scholar
  • 26 Henke E, Nandigama R, Ergun S. Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy. Front Mol Biosci 2019; 6: 160
    CrossrefPubMedSearch in Google Scholar
  • 27 Blachar A, Federle MP, Sosna J. Liver lesions with hepatic capsular retraction. Semin Ultrasound CT MR 2009; 30: 426-435
    CrossrefPubMedSearch in Google Scholar
  • 28 Kelekis NL, Semelka RC, Woosley JT. Malignant lesions of the liver with high signal intensity on T1-weighted MR images. J Magn Reson Imaging 1996; 6: 291-294
    CrossrefPubMedSearch in Google Scholar
  • 29 Fleming M, Ravula S, Tatishchev SF. et al. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol 2012; 3: 153-173
    CrossrefPubMedSearch in Google Scholar
  • 30 Park JH, Kim JH. Pathologic differential diagnosis of metastatic carcinoma in the liver. Clin Mol Hepatol 2019; 25: 12-20
    CrossrefPubMedSearch in Google Scholar
  • 31 Namasivayam S, Martin DR, Saini S. Imaging of liver metastases: MRI. Cancer Imaging 2007; 7: 2-9
    CrossrefPubMedSearch in Google Scholar
  • 32 Outwater E, Tomaszewski JE, Daly JM. et al. Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. Radiology 1991; 180: 327-332
    CrossrefPubMedSearch in Google Scholar
  • 33 Silva AC, Evans JM, McCullough AE. et al. MR imaging of hypervascular liver masses: a review of current techniques. Radiographics 2009; 29: 385-402
    CrossrefPubMedSearch in Google Scholar
  • 34 Baker ME, Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995; 197: 329-337
    CrossrefPubMedSearch in Google Scholar
  • 35 Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 2000; 174: 691-698
    CrossrefPubMedSearch in Google Scholar
  • 36 Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 1994; 190: 49-52
    CrossrefPubMedSearch in Google Scholar
  • 37 Tang M, Li Y, Lin Z. et al. Hepatic nodules with arterial phase hyperenhancement and washout on enhanced computed tomography/magnetic resonance imaging: how to avoid pitfalls. Abdom Radiol (NY) 2020; 45: 3730-3742
    CrossrefPubMedSearch in Google Scholar
  • 38 Patnana M, Menias CO, Pickhardt PJ. et al. Liver Calcifications and Calcified Liver Masses: Pattern Recognition Approach on CT. AJR Am J Roentgenol 2018; 211: 76-86
    CrossrefPubMedSearch in Google Scholar
  • 39 Yu MH, Kim YJ, Park HS. et al. Imaging Patterns of Intratumoral Calcification in the Abdominopelvic Cavity. Korean J Radiol 2017; 18: 323-335
    CrossrefPubMedSearch in Google Scholar
  • 40 Rajesh S, Bansal K, Sureka B. et al. The imaging conundrum of hepatic lymphoma revisited. Insights Imaging 2015; 6: 679-692
    CrossrefPubMedSearch in Google Scholar
  • 41 Colagrande S, Calistri L, Grazzini G. et al. MRI features of primary hepatic lymphoma. Abdom Radiol (NY) 2018; 43: 2277-2287
    CrossrefPubMedSearch in Google Scholar